Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $900,000.

  • BIO-TECHNE's Gains from Investment Securities fell 96.17% to $900,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $900,000, marking a year-over-year decrease of 99.16%. This contributed to the annual value of $9.5 million for FY2025, which is 18.30% down from last year.
  • BIO-TECHNE's Gains from Investment Securities amounted to $900,000 in Q3 2025, which was down 25.00% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Gains from Investment Securities peaked at $122.8 million during Q3 2021, and registered a low of -$141.8 million during Q2 2023.
  • Over the past 3 years, BIO-TECHNE's median Gains from Investment Securities value was $1.2 million (recorded in 2025), while the average stood at -$2.6 million.
  • Per our database at Business Quant, BIO-TECHNE's Gains from Investment Securities spiked by 17,442.86% in 2021 and then slumped by 1,190.77% in 2023.
  • Quarterly analysis of 5 years shows BIO-TECHNE's Gains from Investment Securities stood at $1.3 million in 2021, then soared by 76.92% to $2.3 million in 2022, then slumped by 43.48% to $1.3 million in 2023, then declined by 23.08% to $1.0 million in 2024, then tumbled by 96.17% to $900,000 in 2025.
  • Its last three reported values are $900,000 in Q3 2025, $1.2 million for Q2 2025, and $400,000 during Q1 2025.